Trending now:  
Semaglutide’s impact on obesity-related heart failure with preserved ejection fraction
NOAH-AFNET 6: Oral anticoagulation & atrial high rate episodes
ESC 2023 Highlights
ESC Congress 2023 Highlights
What to expect at ESC Congress 2023

Content for healthcare professionals only

Podcast |

iMODERN: When to treat non-culprit lesions in STEMI

30 Aug 2022
ARTICA Pre-hospital rule out of ACS
Cardiology Update
Cardiology Update
iMODERN: When to treat non-culprit lesions in STEMI

The iMODERN trial (“iFR Guided Multi-vessel Revascularization During Percutaneous Coronary Intervention for Acute Myocardial Infarction.”) trial is an ongoing multinational study. This study will provide important knowledge on the best practice for the assessment and treatment of multi-vessel disease involving ST-segment elevation myocardial infarction (STEMI) patients.

We spoke with Professor Robin Nijveldt, Cardiologist at Radboud University Medical Center in Nijmegen, the Netherlands about this ongoing prospective, randomized controlled, multicentre study.

Learn more at

For more cardiology research news, join Cardiology Update on FacebookTwitterLinkedIn or Instagram.

Keywords: cardiology, cardiologist, heart, medicine, doctor, cardiology-update


Related Topics